Century Therapeutics Inc (IPSC) — Free Cash Flow Generation Index

Latest as of March 2022: 0.95x

Century Therapeutics Inc (IPSC) has a Free Cash Flow Generation Index of 0.95x as of March 2022. Free cash flow of $82.69 Million represents 1% of operating cash flow ($86.75 Million). See IPSC working capital efficiency to evaluate short-term liquidity relative to the company's equity base.

FCF Generation Index

0.95x
Free Cash Flow / Operating CF

Free Cash Flow

$82.69 Million
USD

Operating Cash Flow

$86.75 Million
USD

Capital Expenditures

$4.07 Million
USD

Century Therapeutics Inc Free Cash Flow Generation Index (2015–2022)

Historical FCF Generation Index trend for Century Therapeutics Inc across 2 annual periods. Explore Century Therapeutics Inc (IPSC) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.

Annual Free Cash Flow Generation for Century Therapeutics Inc (2015–2022)

Year-by-year Free Cash Flow Generation Index for Century Therapeutics Inc. For the full company profile including market capitalisation, see Century Therapeutics Inc (IPSC) market capitalisation.

Year FCG Index Free Cash Flow (USD) Operating CF Capital Expenditures YoY Change
2022 -1.18x $-16.55 Million $14.05 Million $30.60 Million ▼ -191.9%
2015 1.28x $133.69 Million $104.30 Million $29.39 Million
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).